EPA:BLC - Euronext Paris - Matif - FR0000035370 - Common Stock - Currency: EUR
EPA:BLC (3/7/2025, 7:00:00 PM)
25.05
0 (0%)
The current stock price of BLC.PA is 25.05 EUR. In the past month the price increased by 13.09%. In the past year, price increased by 39.79%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
AMP.MI | AMPLIFON SPA | 30.68 | 4.72B | ||
FAGR.BR | FAGRON | 17.45 | 1.35B | ||
UPR.I | UNIPHAR PLC | 15.94 | 703.60M | ||
ILM1.DE | MEDIOS AG | 25.09 | 339.28M | ||
TLIK.DE | ARZNEIWERK AG VIDA | N/A | 3.03M |
Bastide Le Confort Médical SA is engaged in the provision and rental of medical supplies and equipment for elderly, sick and handicapped people, and healthcare professionals. The company is headquartered in Caissargues, Occitanie and currently employs 3,651 full-time employees. The firm activity is organized around three families of products and services such as home care equipment and services, respiratory assistance equipment and services, perfusion and nutrition equipment and services, It provides hospital beds, personal assistance products, etc. The firm provides mainly respirators, oxygen concentrators, and oxygen tanks; The offers perfusion, nutrition, and insulin pumps and syringe-drivers. The company offers devices to support diabetic patients towards daily comfort and a normal life. The firm offers wide range of products and services to relieve patients losing their autonomy. The company fer tailor-made, solutions for a secure, humane, and deeply respectful care pathway.
BASTIDE LE CONFORT MEDICAL
Centre d'activite Euro 2000, 12 avenue de la Dame
Caissargues OCCITANIE FR
Employees: 3635
Company Website: https://www.bastideleconfortmedical.com/
Investor Relations: https://bastide-groupe.fr/investisseurs/
Phone: 33466386808
The current stock price of BLC.PA is 25.05 EUR.
The exchange symbol of BASTIDE LE CONFORT MEDICAL is BLC and it is listed on the Euronext Paris - Matif exchange.
BLC.PA stock is listed on the Euronext Paris - Matif exchange.
6 analysts have analysed BLC.PA and the average price target is 29.07 EUR. This implies a price increase of 16.05% is expected in the next year compared to the current price of 25.05. Check the BASTIDE LE CONFORT MEDICAL stock analysts ratings, price target forecast and up-and down grades for more detailed information.
BASTIDE LE CONFORT MEDICAL (BLC.PA) has a market capitalization of 184.37M EUR. This makes BLC.PA a Micro Cap stock.
BASTIDE LE CONFORT MEDICAL (BLC.PA) currently has 3635 employees.
BASTIDE LE CONFORT MEDICAL (BLC.PA) has a support level at 24.8 and a resistance level at 26.5. Check the full technical report for a detailed analysis of BLC.PA support and resistance levels.
The Revenue of BASTIDE LE CONFORT MEDICAL (BLC.PA) is expected to grow by 7.14% in the next year. Check the estimates tab for more information on the BLC.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BLC.PA does not pay a dividend.
BASTIDE LE CONFORT MEDICAL (BLC.PA) will report earnings on 2025-05-15.
BASTIDE LE CONFORT MEDICAL (BLC.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.12).
ChartMill assigns a technical rating of 10 / 10 to BLC.PA. When comparing the yearly performance of all stocks, BLC.PA is one of the better performing stocks in the market, outperforming 94.19% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to BLC.PA. While BLC.PA is still in line with the averages on profitability rating, there are concerns on its financial health.
Over the last trailing twelve months BLC.PA reported a non-GAAP Earnings per Share(EPS) of -0.12. The EPS decreased by -107.95% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -0.14% | ||
ROE | -1.13% | ||
Debt/Equity | 4.3 |
ChartMill assigns a Buy % Consensus number of 83% to BLC.PA. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of -12.79% and a revenue growth 7.14% for BLC.PA